世界の注意欠陥多動性障害(ADHD)治療薬市場予測2021-2027:覚醒剤、非覚醒剤

Market Monitor Globalが発行した調査報告書(MMG21DC17272)
◆英語タイトル:Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21DC17272
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年12月(※2024年版があります。お問い合わせください。)
◆ページ数:94
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

Market Monitor Global社が発行した本調査レポートは、世界の注意欠陥多動性障害(ADHD)治療薬市場について調査し取りまとめました。注意欠陥多動性障害(ADHD)治療薬の世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(覚醒剤、非覚醒剤)、用途別分析(小児、青年、成人)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界の注意欠陥多動性障害(ADHD)治療薬市場規模2021年vs2027年
・世界の注意欠陥多動性障害(ADHD)治療薬市場:売上予測2016年-2027年
・主要企業別の注意欠陥多動性障害(ADHD)治療薬売上・市場シェア・価格
・注意欠陥多動性障害(ADHD)治療薬の種類別市場規模:覚醒剤、非覚醒剤
・注意欠陥多動性障害(ADHD)治療薬の用途別市場規模:小児、青年、成人
・地域別市場規模
・注意欠陥多動性障害(ADHD)治療薬の北米市場:アメリカ市場、カナダ市場、メキシコ市場
・注意欠陥多動性障害(ADHD)治療薬のヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・注意欠陥多動性障害(ADHD)治療薬のアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・注意欠陥多動性障害(ADHD)治療薬の南米市場:ブラジル市場、アルゼンチン市場など
・注意欠陥多動性障害(ADHD)治療薬の中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:Eli Lilly、Perdue Pharma、Johnson & Johnson、Janssen Pharmaceuticals, Inc.、Takeda、Glaxosmith Kline、Novartis、Celltech Group
・世界の注意欠陥多動性障害(ADHD)治療薬の生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・注意欠陥多動性障害(ADHD)治療薬のサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of Attention Deficit Hyperactivity Disorder(ADHD) Drugs in global, including the following market information:
Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Attention Deficit Hyperactivity Disorder(ADHD) Drugs companies in 2020 (%)
The global Attention Deficit Hyperactivity Disorder(ADHD) Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Attention Deficit Hyperactivity Disorder(ADHD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Segment Percentages, By Type, 2020 (%)
Stimulants
Non-Stimulants

Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Segment Percentages, By Application, 2020 (%)
Pediatric
Adolescent
Adults

Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Attention Deficit Hyperactivity Disorder(ADHD) Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Attention Deficit Hyperactivity Disorder(ADHD) Drugs revenues share in global market, 2020 (%)
Key companies Attention Deficit Hyperactivity Disorder(ADHD) Drugs sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Attention Deficit Hyperactivity Disorder(ADHD) Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Perdue Pharma
Johnson & Johnson
Janssen Pharmaceuticals, Inc.
Takeda
Glaxosmith Kline
Novartis
Celltech Group

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by User
1.3 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Overall Market Size
2.1 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size: 2021 VS 2027
2.2 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Attention Deficit Hyperactivity Disorder(ADHD) Drugs Players in Global Market
3.2 Top Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Companies Ranked by Revenue
3.3 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue by Companies
3.4 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales by Companies
3.5 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Attention Deficit Hyperactivity Disorder(ADHD) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size Markets, 2021 & 2027
4.1.2 Stimulants
4.1.3 Non-Stimulants
4.2 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue & Forecasts
4.2.1 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2021
4.2.2 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2022-2027
4.2.3 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue Market Share, 2016-2027
4.3 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales & Forecasts
4.3.1 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2021
4.3.2 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2022-2027
4.3.3 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales Market Share, 2016-2027
4.4 By Type – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2021 & 2027
5.1.2 Pediatric
5.1.3 Adolescent
5.1.4 Adults
5.2 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue & Forecasts
5.2.1 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2021
5.2.2 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2022-2027
5.2.3 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue Market Share, 2016-2027
5.3 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales & Forecasts
5.3.1 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2021
5.3.2 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2022-2027
5.3.3 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales Market Share, 2016-2027
5.4 By Application – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2021 & 2027
6.2 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue & Forecasts
6.2.1 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2021
6.2.2 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2022-2027
6.2.3 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue Market Share, 2016-2027
6.3 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales & Forecasts
6.3.1 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2021
6.3.2 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2022-2027
6.3.3 By Region – Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2027
6.4.2 By Country – North America Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2027
6.4.3 US Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.4.4 Canada Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.4.5 Mexico Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2027
6.5.2 By Country – Europe Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2027
6.5.3 Germany Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5.4 France Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5.5 U.K. Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5.6 Italy Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5.7 Russia Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.5.9 Benelux Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2027
6.6.2 By Region – Asia Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2027
6.6.3 China Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.6.4 Japan Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.6.5 South Korea Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.6.7 India Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2027
6.7.2 By Country – South America Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2027
6.7.3 Brazil Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.7.4 Argentina Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Attention Deficit Hyperactivity Disorder(ADHD) Drugs Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales, 2016-2027
6.8.3 Turkey Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.8.4 Israel Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
6.8.6 UAE Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Eli Lilly Key News
7.2 Perdue Pharma
7.2.1 Perdue Pharma Corporate Summary
7.2.2 Perdue Pharma Business Overview
7.2.3 Perdue Pharma Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.2.4 Perdue Pharma Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Perdue Pharma Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.3.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Johnson & Johnson Key News
7.4 Janssen Pharmaceuticals, Inc.
7.4.1 Janssen Pharmaceuticals, Inc. Corporate Summary
7.4.2 Janssen Pharmaceuticals, Inc. Business Overview
7.4.3 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.4.4 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Janssen Pharmaceuticals, Inc. Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.5.4 Takeda Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Takeda Key News
7.6 Glaxosmith Kline
7.6.1 Glaxosmith Kline Corporate Summary
7.6.2 Glaxosmith Kline Business Overview
7.6.3 Glaxosmith Kline Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.6.4 Glaxosmith Kline Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Glaxosmith Kline Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.4.4 Novartis Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Novartis Key News
7.8 Celltech Group
7.8.1 Celltech Group Corporate Summary
7.8.2 Celltech Group Business Overview
7.8.3 Celltech Group Attention Deficit Hyperactivity Disorder(ADHD) Drugs Major Product Offerings
7.8.4 Celltech Group Attention Deficit Hyperactivity Disorder(ADHD) Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Celltech Group Key News
8 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Production Capacity, Analysis
8.1 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Production Capacity, 2016-2027
8.2 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Attention Deficit Hyperactivity Disorder(ADHD) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Supply Chain Analysis
10.1 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Industry Value Chain
10.2 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Upstream Market
10.3 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Attention Deficit Hyperactivity Disorder(ADHD) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

...

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の注意欠陥多動性障害(ADHD)治療薬市場予測2021-2027:覚醒剤、非覚醒剤(Attention Deficit Hyperactivity Disorder(ADHD) Drugs Market - Global Outlook and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆